BPMC Blueprint Medicines Corp

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include BLU-285, BLU 554, and BLU-667.

$95.78  +3.77 (4.10%)
As of 03/05/2021 15:59:14 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
04/30/2015
57,957,641
426,060
$5,332,682,548
0.00%
SEC Edgar Online
10-Q
10-K
09627Y109
US09627Y1091
BWY52P3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
16.99
3.62
6.72
21.35%
39.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy